Advertisement

Topics

Verastem's blood cancer drug succeeds in late-stage trial

03:05 EDT 6 Sep 2017 | Reuters

(Reuters) - U.S. drug developer Verastem Inc said on Wednesday its drug to treat some types of blood cancer met the main goal in a late-stage study by prolonging the time patients lived without their disease worsening.

Original Article: Verastem's blood cancer drug succeeds in late-stage trial

NEXT ARTICLE

More From BioPortfolio on "Verastem's blood cancer drug succeeds in late-stage trial"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...